The broad long-term objectives of this work are to develop and apply theoretical models to analyze complementary interactions formed during protein folding and binding. The ability of molecules to recognize one another with appropriate affinity and specificity is central to biology and medicine. The clinical activity of pharmaceutical agents is due largely to their ability to recognize and interfere with one or a small number of molecular targets; undesirable side effects are frequently caused by lack of specificity for the correct target. An important area of research involves understanding the design principles of natural protein molecules and developing tools to engineer modified or entirely new molecules by similar principles. The current proposal focuses on (1) further developments in methodology for the study and engineering of molecular structures and binding partners and (2) applications to particular biological molecules of interest. Current algorithms efficiently search side chain rotameric space when the backbone is fixed; we propose new methods to allow incorporation of backbone degrees of freedom or docking degrees of freedom as well. We have previously developed electrostatic optimization techniques that allow computation of idealized complementary binding partners, whose shape and charge distribution lead to high affinity binding. We propose to extend these methods to allow the design of actual ligand molecules that approach the idealized shape and charge distribution. Moreover, while high affinity or stability has been the focus of many design studies, we propose to develop methods that engineer in specificity as well. We will then apply this approach to investigations of the well studied Arc repressor and of proteins involved in phosphate recognition in signal transduction, and we will collaborate with experimentalists who are experts in these systems and will carry out parallel studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM065418-04
Application #
7116257
Study Section
Molecular and Cellular Biophysics Study Section (BBCA)
Program Officer
Wehrle, Janna P
Project Start
2003-09-30
Project End
2008-05-31
Budget Start
2006-09-01
Budget End
2008-05-31
Support Year
4
Fiscal Year
2006
Total Cost
$225,962
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Bonk, Brian M; Tarasova, Yekaterina; Hicks, Michael A et al. (2018) Rational design of thiolase substrate specificity for metabolic engineering applications. Biotechnol Bioeng 115:2167-2182
Shen, Yang; Radhakrishnan, Mala L; Tidor, Bruce (2015) Molecular mechanisms and design principles for promiscuous inhibitors to avoid drug resistance: lessons learned from HIV-1 protease inhibition. Proteins 83:351-72
Shen, Yang; Altman, Michael D; Ali, Akbar et al. (2013) Testing the substrate-envelope hypothesis with designed pairs of compounds. ACS Chem Biol 8:2433-41
Nalam, Madhavi N L; Ali, Akbar; Reddy, G S Kiran Kumar et al. (2013) Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance. Chem Biol 20:1116-24
King, Bracken M; Silver, Nathaniel W; Tidor, Bruce (2012) Efficient calculation of molecular configurational entropies using an information theoretic approximation. J Phys Chem B 116:2891-904
Huggins, David J; Sherman, Woody; Tidor, Bruce (2012) Rational approaches to improving selectivity in drug design. J Med Chem 55:1424-44
Machado, Daniel; Costa, Rafael S; Ferreira, Eugénio C et al. (2012) Exploring the gap between dynamic and constraint-based models of metabolism. Metab Eng 14:112-9
Huggins, David J; Tidor, Bruce (2011) Systematic placement of structural water molecules for improved scoring of protein-ligand interactions. Protein Eng Des Sel 24:777-89
Nalam, Madhavi N L; Ali, Akbar; Altman, Michael D et al. (2010) Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance. J Virol 84:5368-78
Radhakrishnan, Mala L; Tidor, Bruce (2010) Cellular level models as tools for cytokine design. Biotechnol Prog 26:919-37

Showing the most recent 10 out of 34 publications